Drug General Information
Drug ID
D06TWE
Former ID
DIB013516
Drug Name
CLX-0921
Synonyms
CLX-090502; CLX-090503; CLX-090717; CLX-092402
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 1 [526686]
Company
Calyx Therapeutics Inc; Calyx Therapeutics
Structure
Download
2D MOL

3D MOL

Canonical SMILES
N1C(=O)SC(C1=O)Cc1ccc(Oc2ccc(/C(=C\c3cc(cc(c3)OC)OC)/C(<br />=O)OC)cc2)cc1
Target and Pathway
Target(s) Peroxisome proliferator activated receptor gamma Target Info Agonist [526686]
KEGG Pathway PPAR signaling pathway
AMPK signaling pathway
Osteoclast differentiation
Huntington's disease
Pathways in cancer
Transcriptional misregulation in cancer
Thyroid cancer
NetPath Pathway IL1 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
Leptin Signaling Pathway
PANTHER Pathway CCKR signaling map ST
Pathway Interaction Database Noncanonical Wnt signaling pathway
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
Signaling events mediated by HDAC Class I
RXR and RAR heterodimerization with other nuclear receptor
Regulation of retinoblastoma protein
Reactome PPARA activates gene expression
Transcriptional regulation of white adipocyte differentiation
Nuclear Receptor transcription pathway
WikiPathways Wnt Signaling Pathway Netpath
Nuclear Receptors in Lipid Metabolism and Toxicity
Differentiation of white and brown adipocyte
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
Transcriptional Regulation of White Adipocyte Differentiation
Adipogenesis
SREBP signalling
Nuclear Receptors
References
Ref 526686A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential. Metabolism. 2003 Aug;52(8):1012-8.
Ref 526686A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential. Metabolism. 2003 Aug;52(8):1012-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Wang and Dr. Li.